A California bill aimed at providing transparency into prescription drug pricing moved a step closer to reality on Wednesday when a Senate committee approved the legislation.
In a 7 to 2 vote, the state’s Senate Health Committee supported the idea that drug makers should notify state officials about planned price hikes and also justify those increases. The legislation would also require health plans to provide detailed information about drug costs and the portion of premiums attributed to this expense.
About the Author Reprints
